Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions

Affiliations

¹ Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
² Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
³ Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan.
⁴ Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
⁵ Department of Dermatology, Showa University Northern Yokohama Hospital, Yokohama, Japan.
⁶ Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
⁷ Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
⁸ Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
⁹ Department of Dermatology, Faculty of Medicine, Shimane University, Shimane, Japan.
¹⁰ Department of Dermatology, School of Medicine, Nara Medical University, Kashihara, Japan.
¹¹ Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. Electronic address: mushiroda@riken.jp.

Koya Fukunaga et al. J Allergy Clin Immunol Pract. 2024 May.

. 2024 May;12(5):1355-1358.e3.

doi: 10.1016/j.jaip.2024.02.041. Epub 2024 Apr 11.

¹ Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
² Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
³ Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan.
⁴ Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
⁵ Department of Dermatology, Showa University Northern Yokohama Hospital, Yokohama, Japan.
⁶ Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
⁷ Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
⁸ Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
⁹ Department of Dermatology, Faculty of Medicine, Shimane University, Shimane, Japan.
¹⁰ Department of Dermatology, School of Medicine, Nara Medical University, Kashihara, Japan.
¹¹ Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. Electronic address: mushiroda@riken.jp.

No abstract available

Publication types